DOSSIER · 13F Holders · Q2 2026
AVADEL PHARMACEUTICALS CVR (ALKERMES PLC merger)
2 institutions still hold AVADEL PHARMACEUTICALS CVR (ALKERMES PLC merger) as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP G29CVR019·2 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
2 institutions reported AVADEL PHARMACEUTICALS CVR (ALKERMES PLC merger) in Q2 2026. Top-holder concentration data is loading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.